Completed

Phase 2
Age: 18Years - 45Years
All Genders
ID00000273

A Laboratory Model for Heroin Abuse Medications

Led by New York State Psychiatric Institute · Updated on 2017-07-05

8

Participants Needed

2

Research Sites

N/A

Total Duration

On this page

Sponsors

N

New York State Psychiatric Institute

Lead Sponsor

N

National Institute on Drug Abuse (NIDA)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this study is to evaluate the effects of treatment medications (methadone, buprenorphine, LAAM, naltrexone, naltrexone microcapsules, and methoclocinnamox) on I.V. and smoked heroin self-administration."

CONDITIONS

Official Title

A Laboratory Model for Heroin Abuse Medications - 8

Who Can Participate

Age: 18Years - 45Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

Inclusion Criterion

  1. DSM IV criteria for opioid dependence
  2. No major mood, psychotic, or anxiety disorder
  3. Physically healthy
  4. Able to perform study procedures
  5. 21-45 years of age
  6. Current use of i.v. heroin in amounts/frequencies
  7. Not seeking treatment for opioid dependence

Exclusion Criterion

  1. DSM IV criteria for dependence on drugs other
  2. Participants requesting treatment
  3. Participants on parole or probation
  4. Pregnancy or lactation
  5. Birth, miscarriage or abortion with 6 months
  6. Recent history of or current significant violent behavior
  7. Current major Axis I psychopathology, other than heroin dependence ( e.g., mood disorder with functional impairment or suicide risk, schizophrenia), which might interfere with ability to participate in the study
  8. Hepatitis with SGOT or SGPT > 3 times normal
  9. Significant suicide risk
  10. Current or history of chronic pain
  11. Sensitivity, allergy, or contraindication to opioids
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

Trial Site Locations

Total: 2 locations

1

Columbia University

New York, New York, United States, 10032

Status Unknown

2

New York State Psychiatric Institute

New York, New York, United States, 10032

Status Unknown

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial